| Application | Recommended Dilution |
|---|---|
| WB | 1:500-1:2000 |
| FC | 1:50-1:200 |
WARS1, also known as tryptophanyl-tRNA synthetase, plays an essential role in protein biosynthesis by catalyzing the attachment of tryptophan to its cognate tRNA. Beyond its canonical function in translation, WARS1 has garnered significant research interest for its non-canonical activities, particularly as an interferon-induced protein with roles in angiogenesis regulation and immune signaling. The protein can be cleaved to generate fragments with distinct biological functions, making it a compelling target for studies spanning cancer biology, vascular research, and inflammatory responses.
This recombinant monoclonal antibody, clone 8D4, offers the consistency and reproducibility that demanding research workflows require. Developed using recombinant technology in a rabbit host, it provides sequence-defined specificity against human WARS1, eliminating the lot-to-lot variability that can complicate longitudinal studies or multi-site collaborations. The antibody is raised against a synthetic peptide derived from human WARS1 and purified through affinity chromatography to ensure high purity.
Validation studies demonstrate reliable performance across multiple applications. In western blot analysis, the antibody detects a band at the predicted molecular weight of 53 kDa in A-431, HeLa, and HL-60 whole cell lysates, confirming specificity across diverse human cell types. Flow cytometry validation using HepG2 cells shows clear separation between antibody-stained and control populations, supporting intracellular detection applications.
With validated performance in ELISA, western blot, and flow cytometry, this antibody provides flexibility for researchers investigating WARS1 in contexts ranging from interferon-mediated responses to aminoacyl-tRNA synthetase biology and tumor microenvironment studies.
Email: support@cusabio.com
Distributors Worldwide